MYOFOL PLUS®: 3 Nutritional Priorities for PCOS and Preconception

For women living with Polycystic Ovary Syndrome (PCOS), reproductive wellness often involves more than focusing on the ovaries alone. Metabolic health, hormonal function and nutritional status all play important roles, especially when planning pregnancy.
MYOFOL PLUS® from Swiss-based CEDEM AG is a comprehensive food supplement formulated around these interconnected needs.
Combining 2,000 mg myo-inositol, 400 µg folic acid and five additional active ingredients, MYOFOL PLUS® offers a nutritional approach that connects PCOS-focused support with preparation for pregnancy.
Here are three nutritional priorities behind its formulation.
1. PCOS-Focused Nutrition: Understanding the Metabolic Connection
PCOS is a hormonal condition that can affect menstrual regularity, ovulation and metabolic health.
Insulin resistance is a common feature of PCOS and may interact with the hormonal processes involved in ovarian function.
Myo-inositol is a naturally occurring compound involved in intracellular signaling, including pathways associated with insulin activity.
MYOFOL PLUS® provides 2,000 mg of myo-inositol per sachet.
Clinical research has investigated myo-inositol in women with PCOS, particularly for potential metabolic benefits.
However, the 2023 International Evidence-based PCOS Guideline emphasizes that evidence for improvements in ovulation, pregnancy and live-birth outcomes remains uncertain.
MYOFOL PLUS® therefore provides PCOS-focused nutritional support rather than a clinically established treatment for infertility or irregular ovulation.
2. Reproductive Wellness: Supporting Important Biological Processes
Reproductive physiology involves hormonal signaling, cellular metabolism and energy-dependent processes.
Two ingredients in MYOFOL PLUS® have attracted research interest in these areas:
- Vitex agnus-castus extract (2 mg): A botanical ingredient studied for its potential influence on reproductive hormone signaling, including pathways associated with prolactin regulation.
- Coenzyme Q10 (5 mg): A naturally occurring compound involved in mitochondrial energy metabolism, a process relevant to normal cellular function.
These ingredients provide a biological rationale for their inclusion in the formulation.
Nevertheless, MYOFOL PLUS® has not been clinically established to regulate prolactin, normalize menstrual cycles, improve egg quality or increase pregnancy rates.
Women experiencing persistent menstrual irregularities or difficulties conceiving should seek appropriate medical evaluation.
3. Preconception Readiness: Essential Nutrients Before Pregnancy
Good preconception care includes adequate intake of essential vitamins and minerals.
MYOFOL PLUS® brings together four nutrients relevant to this stage:
- Folic Acid (400 µg): Adequate daily intake before conception and during early pregnancy helps reduce the risk of neural tube defects.
- Iron (20 mg): Contributes to normal red blood cell and hemoglobin formation and the reduction of tiredness and fatigue.
- Iodine (150 µg): Contributes to normal thyroid hormone production and thyroid function.
- Selenium (50 µg): Contributes to normal thyroid function and protection of cells from oxidative stress.
The 400 µg folic acid content is particularly relevant because the US Centers for Disease Control and Prevention (CDC) recommends this daily amount for all women capable of becoming pregnant.
However, MYOFOL PLUS® contains Vitex, whose safety during pregnancy has not been established. Women planning pregnancy should consult their healthcare professional before use and promptly review continued supplementation if pregnancy occurs.
MYOFOL PLUS® Formula at a Glance
Each daily sachet contains seven active ingredients:
- Myo-Inositol — 2,000 mg
- Folic Acid — 400 µg
- Iron — 20 mg
- Iodine — 150 µg
- Selenium — 50 µg
- Coenzyme Q10 — 5 mg
- Vitex agnus-castus Extract — 2 mg
The formula combines a compound studied in PCOS-related metabolic pathways with nutrients involved in normal cellular, hematological and thyroid functions.
What Makes MYOFOL PLUS® Different?
MYOFOL PLUS® is designed around a broader nutritional concept than a single-ingredient supplement.
Its key characteristics include:
- PCOS-to-preconception positioning: One formulation connecting metabolic nutrition with preparation for pregnancy.
- 2,000 mg myo-inositol: A clearly defined daily amount of an ingredient studied in PCOS.
- Preconception-aligned folic acid: 400 µg per sachet, matching the general daily recommendation for women capable of pregnancy.
- Seven-ingredient combination: Integrating myo-inositol, selected micronutrients and reproductive-wellness ingredients.
- Practical daily format: One water-soluble sachet per day.
These characteristics distinguish the formula's nutritional approach, but do not establish clinical superiority over other supplements.
How to Take MYOFOL PLUS®
According to CEDEM AG's updated product instructions:
- Empty the contents of one sachet into 150 mL of water.
- Mix until dissolved.
- Take once daily, following the approved product directions.
Do not exceed the recommended daily serving.
Important: Consult a healthcare professional before use when planning pregnancy, particularly because the product contains Vitex. The formula also contains aspartame, a source of phenylalanine, which is relevant to individuals with phenylketonuria (PKU).
Frequently Asked Questions About MYOFOL PLUS®
Does MYOFOL PLUS® help women with PCOS?
MYOFOL PLUS® contains myo-inositol, which has been studied for potential metabolic effects in women with PCOS. However, its impact on ovulation and fertility outcomes remains uncertain.
Can MYOFOL PLUS® improve fertility?
MYOFOL PLUS® is designed for reproductive-health nutrition, but improved conception rates or pregnancy outcomes have not been established for the finished formula.
Does MYOFOL PLUS® contain folic acid?
Yes. Each sachet contains 400 µg folic acid, an important daily amount for women capable of becoming pregnant.
Can MYOFOL PLUS® be taken during pregnancy?
The product should not be assumed suitable during pregnancy because it contains Vitex. Professional advice is necessary before use when planning pregnancy or if pregnancy is suspected or confirmed.
Is MYOFOL PLUS® a fertility medicine?
No. MYOFOL PLUS® is a food supplement intended to complement appropriate nutrition and healthcare. It is not a medicine or a substitute for fertility treatment.
Conclusion: A Comprehensive Approach From PCOS to Preconception
Women's reproductive health involves interconnected metabolic, hormonal and nutritional processes.
MYOFOL PLUS® combines seven active ingredients within one daily sachet, providing a comprehensive nutritional concept that extends from PCOS-focused support to preconception readiness.
With 2,000 mg myo-inositol and 400 µg folic acid, alongside iron, iodine, selenium, CoQ10 and Vitex, the formula addresses complementary nutritional considerations relevant to women of reproductive age.
It should be used with appropriate professional guidance, especially when planning pregnancy, and should not be considered a proven treatment for PCOS-related infertility.
MYOFOL PLUS® — Comprehensive Nutritional Support From PCOS to Preconception.
Explore the official CEDEM AG Women's Health portfolio to learn more about MYOFOL PLUS®.
For related reading, discover MYOFOL® and its PCOS-focused nutritional concept. MYOFOL® is a separate product with a different formulation.
Scientific References
- 2023 International Evidence-based Guideline for the Assessment and Management of PCOS.
- CDC — Folic Acid Safety and Health Outcomes, 2026.
- NCCIH — Chasteberry: Usefulness and Safety.
- European Commission — Authorized Health Claims for Vitamins and Minerals.
Medical disclaimer: This article is for educational purposes and does not replace medical advice. MYOFOL PLUS® is a food supplement, not a medicine. Women with PCOS or those planning pregnancy should seek advice from a qualified healthcare professional before use, particularly because the formula contains Vitex. Follow the approved product instructions.